APA

Messias L. R., Messias A. C. N. V., de Miranda S. M. R., Wiefels C. C., Ferreira A. G., Santos L. M., Teixeira J. A. C., Marostica E. & Mesquita C. T. (20161005). Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction. : International journal of cardiology.

Chicago

Messias L R, Messias A C N V, de Miranda S M R, Wiefels C C, Ferreira A G, Santos L M, Teixeira J A C, Marostica E and Mesquita C T. 20161005. Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction. : International journal of cardiology.

Harvard

Messias L. R., Messias A. C. N. V., de Miranda S. M. R., Wiefels C. C., Ferreira A. G., Santos L. M., Teixeira J. A. C., Marostica E. and Mesquita C. T. (20161005). Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction. : International journal of cardiology.

MLA

Messias L R, Messias A C N V, de Miranda S M R, Wiefels C C, Ferreira A G, Santos L M, Teixeira J A C, Marostica E and Mesquita C T. Abnormal adrenergic activation is the major determinant of reduced functional capacity in heart failure with preserved ejection fraction. : International journal of cardiology. 20161005.